Literature DB >> 10857791

Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis.

K Overzet1, T J Gensler, S J Kim, M E Geiger, W J van Venrooij, K M Pollard, P Anderson, P J Utz.   

Abstract

OBJECTIVE: Proteins that are phosphorylated during apoptosis are commonly precipitated by autoantibodies found in the sera of patients with systemic lupus erythematosus. We sought to determine whether scleroderma autoantigens such as small nucleolar RNPs (snoRNP) also associate with phosphoproteins in response to various cellular stressors.
METHODS: We screened a panel of monoclonal antibodies derived from mice exposed to mercury, a well-characterized murine model of the anti-snoRNP autoimmune response, for the ability to selectively precipitate phosphoproteins from radiolabeled lysates prepared from Jurkat T cells subjected to stressful stimuli.
RESULTS: Monoclonal antibodies reactive with snoRNPs precipitated a phosphoprotein complex (pp42, pp34, and pp23) from lysates prepared from apoptotic cells. Several novel phosphoproteins (pp62 and pp18) were also observed. The phosphorylation and/or recruitment of these proteins to the snoRNP complex is induced by multiple apoptotic stimuli (e.g., Fas ligation, anisomycin, or ultraviolet irradiation), an effect that is blocked by overexpression of Bcl-2. We were unable to demonstrate an association of the phosphoprotein complex with snoRNPs in cells treated with the xenobiotic agent mercury. The snoRNP-associated phosphoprotein complex is composed of serine/arginine (SR) splicing factors, including SRp40.
CONCLUSION: The association of phosphorylated SR proteins with snoRNPs in cells undergoing apoptosis suggests that the immune response to fibrillarin that characterizes a subset of patients with scleroderma may be related to cell death induced by apoptotic stimuli (e.g., Fas ligation, irradiation, or chemical toxins), or by exposure to mercury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857791     DOI: 10.1002/1529-0131(200006)43:6<1327::AID-ANR15>3.0.CO;2-S

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.

Authors:  Y Shav-Tal; M Cohen; S Lapter; B Dye; J G Patton; J Vandekerckhove; D Zipori
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

2.  Exposure of HEp-2 cells to stress conditions influences antinuclear antibody reactivity.

Authors:  Liping Du; Sachiko Fukushima; Annahita Sallmyr; Rolf Manthorpe; Anders Bredberg
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  Identification of candidate genes with pro-apoptotic properties by functional screening of randomly fragmented cDNA libraries.

Authors:  M Hassan; C Matuschek; P A Gerber; M Peiper; W Budach; E Bölke
Journal:  Eur J Med Res       Date:  2010-04-08       Impact factor: 2.175

4.  Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway.

Authors:  Makoto Kamachi; Truc M Le; Susan J Kim; Meghan E Geiger; Paul Anderson; Paul J Utz
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307

5.  An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.

Authors:  Julia Y Wang; Wei Zhang; Victor B Roehrl; Michael W Roehrl; Michael H Roehrl
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 8.786

6.  A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells.

Authors:  Julia Y Wang; Wei Zhang; Jung-Hyun Rho; Michael W Roehrl; Michael H Roehrl
Journal:  Clin Proteomics       Date:  2020-09-21       Impact factor: 3.988

7.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.